Thinking About the Assessment of Risk: September 2017

3.00 CME
180 MINS
$30 FEE
SAVE
Psych Annals September 2017 Cover

Overview

Table of Contents

From Ballpark to Courtroom: How Baseball Explains Risk Assessment

Christopher P. Marett, MD, MPH; and Douglas Mossman, MD

A Review of Violence Risk Assessment for the General Clinician

Mark Chapman, MD

Structured Approaches to Violence Risk Assessment: A Critical Review

Michael Brook, PhD

Thinking About (Completed) Suicide

Sam Libeu, MD; and Stephen H. Dinwiddie, MD

Possible Antidotes for Suicide Risk: What Should We Tell Our Patients?

Sean Bordelon, MD; and Stephen H. Dinwiddie, MD


Sponsorship Statement

This CME activity is jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals.


Support Statement

There is no commercial support for this activity.


Learning Objectives

1. Describe approaches to risk assessment and relevant statistical concepts.

2. Recognize the basic components of violence risk assessment and the methods and tools available to conduct risk assessments.

3. Describe the theory and methodology behind violence risk assessment approaches used in contemporary forensic mental health practice.

4. Define the risk factors associated with completed suicide.

5. Describe which psychiatric treatments have the most evidence for suicide prevention.

Faculty names and affiliations:  See authors above

Guest Editor: Stephen H. Dinwiddie, MD

Reviewer names:  Jan Fawcett, MD, Editor, Psychiatric Annals; Andrew A. Nierenberg, MD, CME Coordinator, Psychiatric Annals


Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.

Faculty members report the following financial relationships:   Jan Fawcett, MD, has no relevant financial relationships to disclose. Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly and Company; EpiQ, Forest; Johnson and Johnson; Labopharm; Merck; Methylation Science; Novartis; PamLabs; PGx Health; Shire; Schering-Plough; Sunovion; Takeda/Lundbeck Pharmaceuticals; Targacept; Teva: Consultant. APSARD; Belvoir Publishing; Boston Center for the Arts; University of Texas Southwestern Dallas; Hillside Hospital; American Drug Utilization Review; American Society for Clinical Psychopharmacology; Bayamon Region Psychiatric Society; Baystate Medical Center; Canadian Psychiatric Association; Columbia University; Douglas Hospital/McGill University; IMEDEX; International Society for Bipolar Disorders; Israel Society for Biological Psychiatry; John Hopkins University; MJ Consulting; Massachusetts Association of College Counselors; Medscape; MBL Publishing; Physicians Postgraduate Press; Ryan Licht Sang Foundation; Slack Publishing; SUNY Buffalo; University of Florida; University of Miami; University of Wisconsin; University of Pisa; SciMed: Honoraria / travel expenses. Appliance Computing, Inc.; Brain Cells, Inc.: Stock options. AHRQ; Cephalon; Forest; Mylan; NIMH; PamLabs; Pfizer Pharmaceuticals; Takeda; Elan; Shire: Grant / research support.

Authors report the following financial relationships: Christopher P. Marett has no relevant financial relationships to disclose. Douglas Mossman has no relevant financial relationships to disclose. Mark Chapman has no relevant financial relationships to disclose. Michael Brook has no relevant financial relationships to disclose. Sam Libeu has no relevant financial relationships to disclose. Stephen H. Dinwiddie has no relevant financial relationships to disclose. Sean Bordelon has no relevant financial relationships to disclose. Signed disclosures are on file at AKH Inc., Advancing Knowledge in Healthcare.


Accreditation statement(s)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and SLACK Incorporated. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.


Credit Designation

AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 3 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Release date:  September 1, 2017. Expiration Date:  October 1, 2020.


How to Participate

To participate in this CME activity, you must read the learning objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, AKH Inc., Advancing Knowledge in Healthcare will issue an AMA PRA Category 1 Credit(s)™ certificate.


Target Audience

This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry and others allied to the field. There are no specific background requirements for participants taking this activity. Learning objectives and author disclosures are found at the beginning of each CME article.


Unlabeled and Investigational Usage Statement

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.


Copyright Statement

Copyright © 2017 by SLACK Incorporated. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher.